Hui Fang

机构：Shanghai Sixth People's Hospital, Huashan Hospital · ORCID：0009-0006-8619-3043

发表论文 50 篇 · 总被引 1178 次 · h-index 18

代表论文

• Prevalence and risk factors of diabetic peripheral neuropathy: A population‐based cross‐sectional study in China (2023 · Diabetes/Metabolism Research and Reviews · 被引 100)
• Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial (2023 · The Lancet Diabetes & Endocrinology · 被引 84)
• Prevalence of painful diabetic peripheral neuropathy in type 2 diabetes mellitus and diabetic peripheral neuropathy: A nationwide cross-sectional study in mainland China (2023 · Diabetes Research and Clinical Practice · 被引 70)
• Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) (2021 · 中国科学通报：英文版 · 被引 65)
• Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities (2024 · JAMA Internal Medicine · 被引 33)
• A mid‑pregnancy risk prediction model for gestational diabetes mellitus based on the maternal status in combination with ultrasound and serological findings (2020 · Experimental and Therapeutic Medicine · 被引 21)